DNAPrint Genomics, Inc. (DNAG)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (900.00%)
Jul 31, 2025, 8:00 PM EDT
DNAPrint Genomics Revenue
DNAPrint Genomics had revenue of $227.56K in the quarter ending September 30, 2007, a decrease of -65.08%. This brings the company's revenue in the last twelve months to $1.93M, down -15.16% year-over-year. In the year 2006, DNAPrint Genomics had annual revenue of $2.43M with 90.75% growth.
Revenue (ttm)
1.93M
Revenue Growth
-15.16%
P/S Ratio
0.00
Revenue / Employee
77.25K
Employees
25
Market Cap
1.30K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2006 | 2.43M | 1.16M | 90.75% |
Dec 31, 2005 | 1.28M | 489.87K | 62.35% |
Dec 31, 2004 | 785.63K | 75.99K | 10.71% |
Dec 31, 2003 | 709.64K | 525.09K | 284.52% |
Dec 31, 2002 | 184.55K | 170.16K | 1,182.58% |
Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 1999 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 1998 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |